Notably, correlations among miR-128-3plevels, activated β-catenin and TGF-β signalling, and pro-epithelial-to-mesenchymal transition/pro-metastatic protein levels are validated in NSCLC patient specimens. This evidence concerns the gene TGFB1 and non-small cell lung carcinoma.